ACROX | CRAZX | ACROX / CRAZX | |
Total Expense Ratio | 1.26 | 0.81 | 156% |
Annual Report Gross Expense Ratio | 1.47 | 0.81 | 181% |
Fund Existence | 11 years | 13 years | - |
Gain YTD | 15.906 | 12.697 | 125% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 2000 | 500% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 96.9M | 2.5B | 4% |
Annual Yield % from dividends | 1.19 | 2.26 | 53% |
Returns for 1 year | 7.90 | 10.33 | 76% |
Returns for 3 years | 66.69 | 34.67 | 192% |
Returns for 5 years | 95.96 | 11.49 | 835% |
Returns for 10 years | 109.86 | 36.36 | 302% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DTCAX | 20.56 | 0.10 | +0.49% |
BNY Mellon Sust US Equity A | |||
FTGRX | 29.69 | 0.13 | +0.44% |
Fidelity Advisor Mega Cap Stock M | |||
ETAHX | 41.71 | 0.05 | +0.12% |
Eventide Healthcare & Life Sciences A | |||
ASCRX | 15.98 | -0.04 | -0.25% |
American Century Small Company R | |||
WRCGX | 6.48 | -0.17 | -2.56% |
William Blair China Growth R6 |